+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Oral Adefovir Drugs Market - Global Forecast 2025-2030- Product Image
Oral Adefovir Drugs Market - Global Forecast 2025-2030- Product Image
Sale

Oral Adefovir Drugs Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6140881
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The oral adefovir market is undergoing substantial transformation, shaped by technological innovation, evolving regulations, and competitive pressures. Senior executives navigating this landscape require actionable insights into shifting supply chains, emerging therapeutic formulations, and nuanced global differentiation strategies.

Market Snapshot: Oral Adefovir Market Trends & Dynamics

The oral adefovir market holds a prominent position within antiviral therapeutics, offering an effective alternative to parenteral treatments for chronic hepatitis B. Multiple branded and generic oral formulations address diverse patient needs through advanced delivery platforms and optimized dosing regimens. Industry participants must manage strategic alliances, intellectual property, and reimbursement negotiations in an environment of growing market complexity. This report provides a holistic overview, distilling regulatory shifts, competitive developments, and recent supply chain disruptions for decision-makers.

Scope & Segmentation of the Oral Adefovir Market

The report delivers deep-dives across pivotal segments and geographies shaping the oral adefovir sector:

  • Product Types: Proprietary branded formulations; Cost-efficient generics.
  • Dosage Forms: Capsules for patient convenience; Oral solutions with flexible dosing; Tablets engineered for consistent release.
  • Strength Variations: 10 mg, 25 mg, and 50 mg, tailored to disease stage and tolerability.
  • Distribution Channels: Community pharmacy (chain and independent); Hospital pharmacy (private, public); Online pharmacy for direct order fulfillment.
  • End Users: Adults as the primary demographic; Geriatrics requiring specialized regimens; Pediatrics needing flexible formulations and caregiver support.
  • Indications: Acute viral infection; Chronic hepatitis B management.
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East and Africa (covering United Kingdom, Germany, France, and more), Asia-Pacific (China, India, Japan, Australia, among others).
  • Key Players: Gilead Sciences, Viatris, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, Cipla, Aurobindo Pharma, Hetero Labs, Sun Pharmaceutical, Cadila Healthcare, Natco Pharma.

Key Takeaways for Senior Stakeholders

  • Technological innovation in prodrug chemistry and digital health solutions is enhancing patient convenience, adherence, and market differentiation.
  • Patent expirations have spurred generic competition, placing pressure on pricing strategies while broadening patient access to oral adefovir therapies.
  • Manufacturers are increasingly leveraging partnerships and integrated care pathways to provide value-added services beyond the core product, responding to a growing emphasis on holistic patient outcomes.
  • Market segmentation by product, strength, and distribution channel enables precise alignment of commercial resources, addressing distinct patient subgroups and healthcare delivery models.
  • Strategic collaborations between pharmaceutical and technology partners accelerate development cycles and facilitate regulatory compliance in diverse geographic contexts.

Tariff Impact: US Trade Measures & Market Response

The 2025 introduction of new tariffs in the United States has affected oral adefovir supply chains and pricing structures. Import duties on raw materials and active ingredients are prompting stakeholders to re-examine sourcing, qualify new suppliers, and shift production footprints toward low-tariff regions such as Southeast Asia and Eastern Europe. Companies are implementing cost-optimization strategies, such as continuous manufacturing, and engaging with authorities for potential tariff exclusions tied to supply security and public health. Successfully maintaining supply continuity and optimizing regional incentives have become central to competitive positioning in this environment.

Methodology & Data Sources

This report utilizes a multi-methodological approach, incorporating secondary research (scientific literature, regulatory files, patents, clinical data) and primary interviews with key opinion leaders, executives, and supply chain experts. Data triangulation, qualitative coding, and quantitative scenario modeling underpin all analysis, while internal peer reviews ensure methodological rigor and reliability.

Why This Report Matters

  • Enables strategic portfolio decisions and risk management in light of evolving supply chain challenges and global regulatory complexity.
  • Equips leaders with granular segmentation intelligence and region-specific insights that drive competitive advantage and value creation.
  • Supports actionable planning for new product launches, alliance formation, and market access strategies in a dynamic therapeutic area.

Conclusion

Senior decision-makers can use this comprehensive overview to navigate the oral adefovir market's evolving landscape, respond to current and emerging pressures, and capitalize on innovation across multiple business functions.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Entry of generic oral adefovir dipivoxil formulations driving competitive pricing pressure
5.2. Investments in formulation technologies to improve adefovir bioavailability and patient compliance
5.3. Rising incidence of chronic hepatitis B accelerating demand for longterm oral adefovir therapies
5.4. Regulatory approval of novel prodrugs aiming to reduce dosing frequency and adverse effects
5.5. Emergence of combination therapies incorporating oral adefovir to address antiviral resistance patterns
5.6. Strategic partnerships between biotech firms and generic manufacturers for global adefovir distribution
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Oral Adefovir Drugs Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Oral Adefovir Drugs Market, by Dosage Form
9.1. Introduction
9.2. Capsule
9.3. Oral Solution
9.4. Tablet
10. Oral Adefovir Drugs Market, by Strength
10.1. Introduction
10.2. 10 Mg
10.3. 25 Mg
10.4. 50 Mg
11. Oral Adefovir Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Community Pharmacy
11.2.1. Chain Pharmacy
11.2.2. Independent Pharmacy
11.3. Hospital Pharmacy
11.3.1. Private Hospital
11.3.2. Public Hospital
11.4. Online Pharmacy
12. Oral Adefovir Drugs Market, by End User
12.1. Introduction
12.2. Adults
12.3. Geriatrics
12.4. Pediatrics
13. Oral Adefovir Drugs Market, by Indication
13.1. Introduction
13.2. Acute Infection
13.3. Chronic Hepatitis B
14. Americas Oral Adefovir Drugs Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Oral Adefovir Drugs Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Oral Adefovir Drugs Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Gilead Sciences, Inc.
17.3.2. Viatris Inc.
17.3.3. Teva Pharmaceutical Industries Limited
17.3.4. Dr. Reddy's Laboratories Limited
17.3.5. Cipla Limited
17.3.6. Aurobindo Pharma Limited
17.3.7. Hetero Labs Limited
17.3.8. Sun Pharmaceutical Industries Limited
17.3.9. Cadila Healthcare Limited
17.3.10. Natco Pharma Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ORAL ADEFOVIR DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ORAL ADEFOVIR DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ORAL ADEFOVIR DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ORAL ADEFOVIR DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ORAL ADEFOVIR DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. ORAL ADEFOVIR DRUGS MARKET: RESEARCHAI
FIGURE 28. ORAL ADEFOVIR DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 29. ORAL ADEFOVIR DRUGS MARKET: RESEARCHCONTACTS
FIGURE 30. ORAL ADEFOVIR DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ORAL ADEFOVIR DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY 10 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY 10 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY 25 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY 25 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY 50 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY 50 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY GERIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY ACUTE INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY ACUTE INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY CHRONIC HEPATITIS B, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL ORAL ADEFOVIR DRUGS MARKET SIZE, BY CHRONIC HEPATITIS B, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS ORAL ADEFOVIR DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 104. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 105. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 106. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 107. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 110. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 111. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 112. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 113. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. CANADA ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 120. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 121. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 122. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 123. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 124. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 125. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 126. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 127. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 128. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 129. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. MEXICO ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 199. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 202. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 203. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 204. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 205. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 208. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 209. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 210. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 211. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. GERMANY ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 218. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 219. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 220. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 221. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 224. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 225. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 226. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 227. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. FRANCE ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 250. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 251. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 252. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 253. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 256. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 257. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 262. ITALY ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 263. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 264. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 265. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 266. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 267. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 268. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 269. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 272. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 273. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 274. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 275. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 278. SPAIN ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 281. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 282. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 295. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 296. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 297. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 298. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 299. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 300. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 301. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 304. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 311. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 312. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 313. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 314. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 315. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 316. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 317. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 320. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA ORAL ADEFOVIR DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 327. DENMARK ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 328. DENMARK ORAL ADEFOVIR DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 329. DENMARK ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 330. DENMARK ORAL ADEFOVIR DRUGS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 331. DENMARK ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2018-2024 (USD MILLION)
TABLE 332. DENMARK ORAL ADEFOVIR DRUGS MARKET SIZE, BY STRENGTH, 2025-2030 (USD MILLION)
TABLE 333. DENMARK ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. DENMARK ORAL ADEFOVIR DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. DENMARK ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2018-2024 (USD MILLION)
TABLE 336. DENMARK ORAL ADEFOVIR DRUGS MARKET SIZE, BY COMMUNITY PHARMACY, 2025-2030 (USD MILLION)
TABLE 337. DENMARK ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2018-2024 (USD MILLION)
TABLE 338. DENMARK ORAL ADEFOVIR DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, 2025-2030 (USD MILLION)
TABLE 339. DENMARK ORAL ADEFOVIR DRUGS MARKET SIZE, BY END USER, 2

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Oral Adefovir Drugs market report include:
  • Gilead Sciences, Inc.
  • Viatris Inc.
  • Teva Pharmaceutical Industries Limited
  • Dr. Reddy's Laboratories Limited
  • Cipla Limited
  • Aurobindo Pharma Limited
  • Hetero Labs Limited
  • Sun Pharmaceutical Industries Limited
  • Cadila Healthcare Limited
  • Natco Pharma Limited

Related Topics

Related Reports

Adefovir Intermediate Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Adefovir Intermediate Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Adefovir Dipivoxil API Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Adefovir Dipivoxil API Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Adefovir (CAS 106941-25-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Adefovir (CAS 106941-25-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Adefovir Dipivoxil (CAS 142340-99-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Adefovir Dipivoxil (CAS 142340-99-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Hepatitis Drugs Market Report 2025 - Product Image

Hepatitis Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.